Systemic Inflammation Response Index is a Prognostic Risk Factor in Patients with Hepatocellular Carcinoma Undergoing TACE

BACKGROUND: Mounting evidence has shown that systemic inflammation response index (SIRI), a novel prognostic biomarker based on peripheral lymphocyte, neutrophil and monocyte counts, is associated with poor prognosis for several tumors. However, the prognostic value of SIRI in patients with hepatoce...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Tian-Cheng, An, Tian-Zhi, Li, Jun-Xiang, Pang, Peng-Fei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8232961/
https://www.ncbi.nlm.nih.gov/pubmed/34188570
http://dx.doi.org/10.2147/RMHP.S316740

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8232961/
https://www.ncbi.nlm.nih.gov/pubmed/34188570
http://dx.doi.org/10.2147/RMHP.S316740

Ejemplares similares